2026 SEEG The Course

Neurologist with extensive specialist experience in epileptology and EEG, including stereo-EEG. Following UK neurology training, Prof. McGonigal spent around 20 years in France, where she studied and practised stereo-EEG methodology, contributing to its evolution through clinical research.

Her research interests include seizure semiology and its neural correlates, and she has written and lectured widely on these topics. She took up her current post in Australia in 2022 and continues to develop the use of stereo-EEG alongside an associated clinical research programme.

Si tu veux, je peux aussi te faire une version un peu plus premium et homogène avec les autres bios (même ton, même structure), ça donnera un rendu beaucoup plus pro sur Epilepsy Courses.

Dr. Anna Miserocchi is a consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery in London, UK, specializing in epilepsy and functional tumour surgery. His research focuses on the use of novel multimodality imaging to improve the safety and precision of neurosurgical procedures, as well as to enhance diagnostic accuracy.

Currently, he is developing a neurosurgical planning platform specifically for epilepsy surgery called EpiNav. This platform integrates various imaging modalities such as fMRI, DTI, PET, SPECT, MEG, EEG / fMRI, and 3D angiography, enabling safer surgical planning and navigation during epilepsy procedures. His goal is to provide surgeons with advanced tools to better visualize and protect critical brain structures.

A key focus of his work is the integration of functional imaging into the surgical microscope within the interventional MRI environment. This approach aims to reduce neurological deficits and improve patient outcomes during resective surgery.

He has also completed the first randomized controlled surgical trial comparing frameless stealth-guided implantation with robotic implantation of intracranial electrodes for stereo-EEG. This study aimed to evaluate the safety and accuracy of electrode placement using different surgical techniques.

Dr. Birgit Frauscher is a clinician scientist whose career is dedicated to improving the diagnosis and prognosis of people with epilepsy by developing new methods based on advanced electroencephalography techniques. Her work focuses on better localizing the epileptic focus in order to improve treatment outcomes and ultimately achieve the best possible quality of life for patients. She is currently the Director of the Duke Comprehensive Epilepsy Center and holds a secondary appointment with the Department of Biomedical Engineering at the Duke Pratt School of Engineering.

Her academic journey began at the Medical University of Innsbruck in Austria, where she completed her medical training, residency in neurology, and subspecialty training in electroencephalography, epilepsy, and sleep medicine. Early in her medical studies, she developed a strong interest in electroencephalography and its potential to provide key insights into brain function. After completing her clinical training in 2008, she pursued further research training and successfully completed her habilitation degree in 2011.

To further specialize in intracranial EEG and signal analysis, she undertook a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University, Canada, between 2013 and 2015. She subsequently joined the Montreal Neurological Institute and Hospital as an Attending Epileptologist, later becoming Group Leader in Epilepsy and Professor of Neurology.

Her research interests include:

i) The development of novel seizure-independent EEG markers for the epileptogenic zone to achieve more accurate epilepsy diagnosis.

ii) The investigation of the interactions between sleep and epilepsy.

iii) The use of invasive intracranial EEG to study brain physiology during wakefulness and sleep in order to better distinguish normal from abnormal intracranial EEG activity.

Dr. Frauscher has published more than 200 peer-reviewed papers dedicated to epilepsy and sleep and has an H-index of 69. Her academic work has been recognized with several prestigious awards, including Clinician-Scientist Awards from the FRSQ (2018–2023), the Michael Prize of the International League Against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015).

Dr. McKhann is the Director of Epilepsy Surgery, Brain Mapping for Tumors and Epilepsy, and Adult Hydrocephalus at Columbia University Irving Medical Center / New York Presbyterian Hospital. He has over 20 years of experience at CUIMC / NYP, combining clinical skill and compassionate care to maximize patient outcomes. He is a member of both the Columbia P&S Virginia Apgar Academy of Medical Educators and the P&S Academy of Clinical Excellence. His areas of particular technical expertise include awake brain mapping, epilepsy surgery, low-grade glioma surgery, minimally invasive computer-guided microneurosurgery, and stereotactic laser ablation for tumors and epilepsy.

Dr. McKhann also works as a translational neuroscientist, directing the Epilepsy Neurophysiology Laboratory, helping lead the multi-departmental study of Cognitive Neurophysiology together with Catherine Schevon MD, PhD and Charles Schroeder PhD, and collaborating extensively with the Gabriele Bartoli Brain Tumor Research Laboratory. His basic and clinical research has been funded by the National Institutes of Health, the American Association of Neurological Surgeons, the Klingenstein Foundation, the Charles A. Dana Foundation, the New York Academy of Medicine, Parents Against Childhood Epilepsy, the Irving Center for Clinical Research, CURE, and the Tuberous Sclerosis Alliance.

Dr. McKhann graduated Phi Beta Kappa and Magna Cum Laude from Duke University, with Research Honors for his investigations into brain tumor immunobiology. He attended Yale School of Medicine, where he was AOA, Cum Laude, a Farr Scholar, and one of five recipients of the medical school’s highest thesis award. Dr. McKhann trained in Neurological Surgery at the University of Washington, as well as at Atkinson Morley’s Hospital in Wimbledon, England.

Si tu veux, je peux aussi te faire une version plus courte et plus marketing pour Epilepsy Courses (genre bio speaker premium pour crédibiliser la page et améliorer la conversion).

Dr. Gonzalez-Martinez is a board-certified neurosurgeon subspecialized in epilepsy and functional neurosurgery. He is the Director of Epilepsy and Movement Disorders Surgery, Co-Director of the Epilepsy Center, and Director of the Cortical Systems Laboratory at the University of Pittsburgh Medical Center.

Dr. Gonzalez is a world-renowned surgeon who has published more than 200 peer-reviewed articles and book chapters related to epilepsy surgery and methods of brain mapping for patients with medically intractable epilepsy and movement disorders. He has been serving the American Society of Stereotactic and Functional Neurosurgery as a member of the executive committee for the past six years, developing highly relevant projects and topics related to the field of functional neurosurgery and epilepsy.

Dr. Gonzalez is a medical pioneer in novel surgical methods for treating medically refractory seizures, such as stereo-electroencephalography (SEEG), SEEG-guided laser ablative procedures, neuromodulatory interventions, and robotic-guided surgeries. He has introduced innovative surgical approaches for the first time in the United States and other countries. His particular field of interest and academic focus relate to neuro-electrophysiology, intracranial signal processing, and behavioral neuroscience.

Combined, his clinical and basic science efforts have guided his academic and clinical pathway toward safer and more efficient treatments for patients with severe seizures and movement disorders. His work promotes symptom improvement alongside better functional outcomes and overall quality of life.

Louis Maillard has been leading the Patrick Chauvel Epileptology Unit at the Regional University Hospital of Nancy since 2005. This unit is recognized as a tertiary French and European Reference Center for rare and drug-refractory epilepsies (ERN EPICARE). Louis is a Professor of Neurology at Lorraine University and a member of the Clinical and Neuroscience Research Team at Lorraine University, Centre National de la Recherche Scientifique (CNRS), UMR 7365. Additionally, he chairs the Scientific Board of the French Clinical Neurophysiology Society and is a member of the ILAE Task Force on Diagnostic Methods / EEG.

Louis Maillard completed a clinical fellowship at the Marseille Epileptology Unit from 2003 to 2005 and earned a PhD in neuroscience at the University of Marseille under the supervision of Professors Patrick and Catherine Chauvel. His research interests and publications focus on drug-resistant epilepsies, with several key objectives:

1. Improving the delineation of the epileptogenic zone using both Stereo-Electroencephalography (SEEG) and Electrical Source Imaging.
2. Enhancing post-surgical cognitive outcomes, particularly in language and visual recognition, through electrical cortical stimulation, intracerebral evoked potentials, and cortico-cortical evoked potentials.

Louis Maillard has served as a tutor and faculty member at numerous international workshops and congresses on SEEG and drug-resistant epilepsies. He chaired the Special Interest Group of the American Epilepsy Society (AES) dedicated to SEEG in December 2024.

After completing his medical and scientific training inNeurology and Neuroscience, Dr. Patrick Chauvel became a researcher at INSERM(Institut National de la Santé et de la Recherche Médicale) in Paris (1975).There, he began his pioneering work in experimental and clinical research onthe mechanisms of epilepsy. Under the mentorship of Talairach and Bancaud atHôpital Sainte-Anne/Université René Descartes in Paris, he advancedstereo-electroencephalography (SEEG) as a presurgical method using intracerebralelectrodes for epilepsy surgery (1975–1990). His research has focused on thepathophysiology of the epileptogenic zone, the emergence of seizure semiology,and human cerebral cortex physiology. Notably, he championed the concept of anepileptogenic network, moving beyond the classical "epileptic focus"model, and pioneered new insights into markers of the epileptogenic zone andfocal epilepsy semiology.  

Succeeding Jean Bancaud, Dr. Chauvel served as Director ofthe SEEG Unit at Hôpital Sainte-Anne (1986–1990), then as Professor andChairman of Neurology in Rennes (1990–1997), where he established an innovativeEpilepsy Unit integrating clinical care and research. Later, he becameProfessor and Chairman of Clinical Neurophysiology and Director of the INSERMInstitute of Systems Neuroscience in Marseille (1997–2014). In 2014, he joinedthe Cleveland Clinic’s Epilepsy Center to advance SEEG-based presurgical evaluationin North America, while also serving as Professor of Neurology at the ClevelandClinic Lerner College of Medicine (Case Western Reserve University).Additionally, as an Honorary Professor at the University of Queensland(Brisbane), he guided the development of SEEG-based epilepsy surgery andresearch programs. He later held appointments as Professor of Neurology at theUniversity of Pittsburgh and Neurologist at UPMC.  

Currently, Dr. Chauvel is a researcher at the ClevelandClinic Epilepsy Center, where he is developing novel SEEG-based methods forpresurgical evaluation of drug-resistant epilepsy and researching biomarkers ofthe epileptogenic zone and the neural mechanisms underlying seizuresemiology.  

He is a Member of the Royal Academy of Medicine of Belgiumin recognition of his contributions to the field.  

Dr. McGonigal is a neurologist with extensive specialist experience in epileptology and EEG, including stereo-EEG. Following UK neurology training, Prof McGonigal spent around 20 years in France where she studied and practised stereo-EEG methodology, contributing to its evolution through clinical research. Her research interests include seizure semiology and its neural correlates, and she has written and lectured widely on these. She took up her current post in Australia in 2022, and continues to develop use of stereo-EEG with an associated clinical research programme.

Dr. Nica is a Neurologist and Neurophysiologist at Rennes University Hospital in France. After completing an internship in neuropediatrics then adult neurology in Bucharest and Rennes, Dr. Nica has been working as a neurologist and neurophysiologist for over 20 years at the University Hospital of Rennes, in the Epileptology Unit of which she became medical director. Her field of expertise is drug-resistant epilepsy surgery, more specifically ictal semiology and intracerebral electrophysiology. She is actively involved in training and teaching in epileptology, particularly in the field of EEG-video and SEEG, in France and abroad. In 2022-2023, she helped train the team and launch the adult SEEG program at the Rothschild Ophthalmological Foundation in Paris. She is a permanent member of the INSERM U1099 Unit of the Rennes Signal and Image Processing Laboratory, CinetyKs team, and as such participates in epileptology research, particularly in the field of EEG and SEEG signal analysis.

‍

Anna Elisabetta Vaudano, M.D., Ph.D., is an Assistant Professor in the Department of Biomedical, Metabolic and Neural Sciences, at University of Modena and Reggio Emilia (Italy) where she is also a practicing neurologist who specializes in treating patients with epilepsy. Dr. Vaudano earned her medical degree at Turin University in Italy. She then completed a residency in neurology and PhD in Neuroscience at University of Rome “La Sapienza”. During her residency and PhD, she covered the position of Visiting Research Fellow at University College of London, UK. In her medical practice and research, Dr Vaudano focuses on the adoption of advanced imaging tools (particularly EEG-fMRI) to improve diagnosis and treatment of epilepsy. She also explores way to help for the identification of the epileptogenic zone by means of effective connectivity approaches on imaging data. Since 2021, she chairs the Neuroimaging Task Force of the Diagnostic Commission of the International League against Epilepsy (ILAE).

Dr. Anna Miserocchi is a consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery in London, UK, specializing in epilepsy and functional tumour surgery. His research focuses on using novel multimodality imaging to improve the safety and precision of neurosurgical procedures, as well as to enhance diagnostic accuracy.

Currently, he is developing a neurosurgical planning platform specifically for epilepsy surgery called EpiNav. This platform integrates various imaging modalities, such as fMRI, DTI, PET, SPECT, MEG, EEG/fMRI, and 3D angiography, allowing for safer planning and navigation during epilepsy surgeries. His aim is to provide surgeons with the tools to better visualize and protect critical areas of the brain during these procedures.

A key focus of his work has also been integrating functional imaging into the surgical microscope within the interventional MRI. This is part of his efforts to reduce neurological deficits in patients during resective surgery.

He has also completed the first randomized controlled surgical trial to compare frameless stealth-guided implantation against robotic implantation of intracranial electrodes for stereoEEG. This trial aimed to determine the safety and accuracy of electrode placement with different surgical techniques.

‍

Dr. Birgit Frauscher is a clinician scientist whose career is dedicated to improve diagnosis and prognosis of people with epilepsy by developing new methods based on advanced
electroencephalography techniques to better localize the epileptic focus in order to improve epilepsy treatment outcomes and ultimately achieve the best possible quality of life. She is
currently holding the position of Director of the Duke Comprehensive Epilepsy Center and holds a secondary appointment with the Department of Biomedical Engineering at the Duke
Pratt School of Engineering.
‍
Her academic journey started at the Medical University of Innsbruck in Austria, where she accomplished her medical training, residency in neurology, and subspecialty training in
electroencephalography, epilepsy and sleep medicine. Early in her career during Medical School she became fascinated by the technique of electroencephalography and how it allows
to draw important conclusions on brain function. After completion of her clinical training in 2008, she underwent subsequent research training resulting in the successful completion of
her habilitation degree in 2011. To specialize on intracranial EEG and signal analysis, she spent a visiting professorship at the Montreal Neurological Institute and Hospital, McGill
University in Canada between 2013 – 2015. Subsequently, she served at the Montreal Neurological Institute and Hospital as an Attending Epileptologist and later as Group Leader
of Epilepsy and Professor of Neurology.
‍
Her research interests include i) the development of novel seizure-independent EEG markers for the epileptogenic zone in order to achieve a more accurate diagnosis of epilepsy, ii) the
investigation of the important interactions between sleep and epilepsy, and iii) the use of the unique possibility of invasive intracranial EEG for studying brain physiology during
wakefulness and sleep in order to better delineate normal from abnormal intracranial EEG activity.
‍
Dr. Frauscher’s publication record holds over 200 peer-reviewed papers dedicated to epilepsy and sleep with a H-index of 69. Her scholarly endeavors have earned her several prestigious
awards, including Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019) and the Ernst Niedermeyer Prize from the
Austrian Epilepsy Society (2015).

‍

Dr. McKhann is the Director of Epilepsy Surgery, Brain Mapping for Tumors and Epilepsy, and Adult Hydrocephalus at Columbia University Irving Medical Center/New York Presbyterian Hospital. He has over 20 years of experience at CUIMC/NYP, combining clinical skill and compassionate care to maximize patient outcomes. He is a member of both the Columbia P&S Virginia Apgar Academy of Medical Educators and the P&S Academy of Clinical Excellence. His areas of particular technical expertise include awake brain mapping; epilepsy surgery; low grade glioma surgery; minimally invasive, computer guided microneurosurgery; and stereotactic laser ablation for tumors and epilepsy.‍Dr. McKhann also works as a translational neuroscientist, directing the Epilepsy Neurophysiology Laboratory; helping lead the multi-departmental study of Cognitive Neurophysiology together with Catherine Schevon MD, Ph.D. and Charles Schroeder, PhD; and collaborating extensively with the Gabriele Bartoli Brain Tumor Research Laboratory. His basic and clinical research has been funded by the National Institutes of Health, the American Association of Neurological Surgeons, the Klingenstein Foundation, the Charles A. Dana Foundation, the New York Academy of Medicine, Parents Against Childhood Epilepsy, the Irving Center for Clinical Research, CURE, and the Tuberous Sclerosis Alliance.‍Dr. McKhann graduated Phi Beta Kappa and Magna Cum Laude from Duke University, with Research Honors for his investigations into brain tumor immunobiology. He attended Yale School of Medicine where he was AOA, Cum Laude, a Farr Scholar, and one of five recipients of the medical school’s highest thesis award. Dr. McKhann trained in Neurological Surgery at the University of Washington, as well as Atkinson Morley’s Hospital in Wimbledon, England.

Dr. Shaker graduated from Tishreen Medical School in Syria and had a research fellowship in Alzheimer’s disease at New York University. He completed his neurology residency at Spectrum Health Hospital and served as a chief resident. After that, he completed a second fellowship in clinical neurophysiology at Cleveland Clinic Foundation. Currently, Dr. Shaker is a clinical assistant professor and Stereotactic electroenecephalogram director at Mercy health Saint Mary’s, Michigan State University.

Louis Maillard has been leading the Patrick Chauvel Epileptology Unit at the Regional University Hospital of Nancy since 2005. This unit is recognized as a tertiary French and European Reference
Center for rare and drug-refractory epilepsies (ERN EPICARE). Louis is a Professor of Neurology at Lorraine University and a member of the Clinical and Neuroscience Research Team at
Lorraine University, Centre National de la Recherche Scientifique (CNRS), UMR 7365. Additionally, he chairs the Scientific Board of the French Clinical Neurophysiology Society and is a member of the ILAE
Task Force on Diagnostic Methods/EEG.
‍
Louis Maillard completed a clinical fellowship at the Marseille Epileptology Unit from 2003 to 2005 and earned a PhD in neuroscience at the University of Marseille under the supervision of Professors
Patrick and Catherine Chauvel. His research interests and publications focus on drug-resistant epilepsies, with several key objectives:
1. Improving the delineation of the epileptogenic zone using both Stereo-
Electroencephalography (SEEG) and Electrical Source Imaging.

2. Enhancing post-surgical cognitive outcomes, particularly in language and visual recognition,
through electrical cortical stimulation, intra-cerebral evoked potentials, and cortico-cortical
evoked potentials.
‍
Louis Maillard has served as a tutor and faculty member at numerous international workshops and congresses on SEEG and drug-resistant epilepsies. He chaired the Special Interest Group of the
American Epilepsy Society (AES) dedicated to SEEG in December 2024.

‍

Dr. Gonzalez-Martinez is a board-certified neurosurgeon subspecialized in epilepsy and functional neurosurgery. He is the director of the epilepsy and movement disorders surgery, Co-Director of the Epilepsy Center and Director of the Cortical Systems Laboratory at the University of Pittsburgh Medical Center.Dr. Gonzalez is a world-renowned surgeon who have published more than 200 peer-reviewed articles and book chapters related to epilepsy surgery and methods of brain mapping for patients with medically intractable epilepsy and movement disorders. He has been serving the American Society of Stereotactic and Functional Neurosurgery in the capacity of member of the executive committee for the last 6 years, developing high relevant projects and topics related to the field of functional neurosurgery and epilepsy.Dr. Gonzalez is a medical pioneer in novel surgical methods for treating medically refractory seizures such as stereo-electroencephalography, SEEG guided laser ablative procedures, neuromodulatory interventions and robotic guided surgeries, bringing for the first time innovative surgical interventions to the United States and other countries. His particular field of interest and academic drive is related to neuro-electrophysiology, intracranial signal processing and behavioral neuroscience studies.Combined, the clinical and basic science efforts have been guiding his academic and clinical pathway for safer and more efficient methods for treating patients with severe seizures and abnormal movement disorders, promoting the improvement of symptoms, in combination with better functional and quality of life outcomes.

Luke Henry, PhD, joined the Department of Neurological Surgery in November of 2015. Dr. Henry completed his doctorate in clinical neuropsychology, specializing in research and intervention, at the Université de Montréal in 2011. He then moved to Pittsburgh where he completed a post-doctoral fellowship at the UPMC Sports Concussion Program. Dr. Henry worked for two years as a clinical instructor within the concussion program before joining the Department of Neurological Surgery.

In his current role, Dr. Henry is responsible for pre- and post-operative neuropsychological testing for a variety of pathologies/conditions including movement disorders, epilepsy, Chiari malformations, brain tumors and post-TBI assessments. He is also actively involved with various research endeavors with other faculty members within the department. Dr. Henry is the lead neuropsychologist in the department, overseeing the growth of neuropsychological services within the department and in collaboration with other departments. He is also involved with doctoral-level training for clinical psychology students from the University of Pittsburgh and Chatham University. Additionally, he is the instructor for the graduate-level cognitive assessment class at the University of Pittsburgh where he is an adjunct professor.

‍

After completing his medical and scientific training inNeurology and Neuroscience, Dr. Patrick Chauvel became a researcher at INSERM(Institut National de la Santé et de la Recherche Médicale) in Paris (1975).There, he began his pioneering work in experimental and clinical research onthe mechanisms of epilepsy. Under the mentorship of Talairach and Bancaud atHôpital Sainte-Anne/Université René Descartes in Paris, he advancedstereo-electroencephalography (SEEG) as a presurgical method using intracerebralelectrodes for epilepsy surgery (1975–1990). His research has focused on thepathophysiology of the epileptogenic zone, the emergence of seizure semiology,and human cerebral cortex physiology. Notably, he championed the concept of anepileptogenic network, moving beyond the classical "epileptic focus"model, and pioneered new insights into markers of the epileptogenic zone andfocal epilepsy semiology.  

Succeeding Jean Bancaud, Dr. Chauvel served as Director ofthe SEEG Unit at Hôpital Sainte-Anne (1986–1990), then as Professor andChairman of Neurology in Rennes (1990–1997), where he established an innovativeEpilepsy Unit integrating clinical care and research. Later, he becameProfessor and Chairman of Clinical Neurophysiology and Director of the INSERMInstitute of Systems Neuroscience in Marseille (1997–2014). In 2014, he joinedthe Cleveland Clinic’s Epilepsy Center to advance SEEG-based presurgical evaluationin North America, while also serving as Professor of Neurology at the ClevelandClinic Lerner College of Medicine (Case Western Reserve University).Additionally, as an Honorary Professor at the University of Queensland(Brisbane), he guided the development of SEEG-based epilepsy surgery andresearch programs. He later held appointments as Professor of Neurology at theUniversity of Pittsburgh and Neurologist at UPMC.  

Currently, Dr. Chauvel is a researcher at the ClevelandClinic Epilepsy Center, where he is developing novel SEEG-based methods forpresurgical evaluation of drug-resistant epilepsy and researching biomarkers ofthe epileptogenic zone and the neural mechanisms underlying seizuresemiology.  

He is a Member of the Royal Academy of Medicine of Belgiumin recognition of his contributions to the field.  

Prachi Parikh, MD, is an Assistant Professor of Neurology at Duke University Medical Center specializing in epilepsy, clinical neurophysiology, and sleep medicine. She treats complex, refractory epilepsy, focusing on personalized treatment plans, including medications and neuromodulation. Dr. Parikh completed her fellowship and residency at the Cleveland Clinic Foundation.

Dr. Zaghloul received his B.Sc. degree from MIT in 1995 and his M.D. and Ph.D. degrees from the University of Pennsylvania in 2003. His graduate work focused on developing silicon models of visual processing in the mammalian retina with Dr. Kwabena Boahen. Dr. Zaghloul completed a residency in Neurological Surgery in 2010 from the University of Pennsylvania. During this time, he completed postdoctoral research with Dr. Michael Kahana, investigating the neural correlates of human memory encoding, decision, and reward. Dr. Zaghloul has completed clinical fellowships in Epilepsy Surgery and in DBS Surgery. Dr. Zaghloul joined NINDS as a Staff Clinician in 2010, and as an Investigator in 2013. He also serves as the Chief of the Surgical Neurology Branch. His laboratory is focused on investigating the neural mechanisms underlying human cognitive function.